2019
DOI: 10.1111/jce.14129
|View full text |Cite
|
Sign up to set email alerts
|

Electrocardiographic changes in loperamide toxicity: Case report and review of literature

Abstract: Introduction Loperamide, an antidiarrheal agent, is a µ‐opioid receptor agonist increasingly abused to prevent opioid withdrawal or to produce euphoric effects. At supra‐therapeutic doses, loperamide can cause cardiac toxicity due to blockade of Na and IKr channels, resulting in wide QRS rhythms, severe bradycardia, prolonged QTc, polymorphic ventricular tachycardia, cardiac arrest, and death. There are limited data on the cardiotoxic effects of high dose loperamide. Methods and Results A case report of lopera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 36 publications
0
14
0
Order By: Relevance
“…Unlike other µ-receptor agonists, loperamide has less CNS activity. 3 When it was first developed, loperamide was listed as a schedule II medication. By 1988, loperamide was marketed as a nonprescription medication because of its low abuse potential relative to other medications within its class.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Unlike other µ-receptor agonists, loperamide has less CNS activity. 3 When it was first developed, loperamide was listed as a schedule II medication. By 1988, loperamide was marketed as a nonprescription medication because of its low abuse potential relative to other medications within its class.…”
Section: Discussionmentioning
confidence: 99%
“…Multiple conduction abnormalities have been reported, including prolonged QTc, VT/VF, torsades de pointes, and even sudden cardiac death. 3,7 Since loperamide’s approval in 1976, 48 cases of serious cardiac complications have been reported to the FDA. Of these 48, 10 patients died and 31 were hospitalized.…”
Section: Discussionmentioning
confidence: 99%
“…It can also, when ingested in very excessive doses, cause cardiotoxicity. Most commonly reported cardiac manifestations are prolonged QT interval and ventricular tachyarrhythmias [5].…”
Section: Discussionmentioning
confidence: 99%
“…It pumps potassium out of the cardiac cell and plays an important role in repolarization of action potential. Loss of function of this channel is associated with hereditary long QT syndrome [5].…”
Section: Discussionmentioning
confidence: 99%
“…Our case consumed 200 mg/day for 7 days and also had TdP in addition to VT storm. A recent review on the electrocardiographic changes in loperamide toxicity was done by Teigeler et al 5. The review had 36 cases with median dose of loperamide 200 mg (134–400 mg), median QTc interval 620 ms (565–701 ms) and VT was experienced by 24/36 (67%) of patients.…”
Section: Descriptionmentioning
confidence: 99%